Table 2.

Multivariate analysis: breast and bowel screening uptakes by deprivation

Cancer screening Programme/Round	Deprivation	Number	Uptake (%)	Adjusted OR (95% CI)
	1 & 2 (Least)	15535	80.86	1 (-)
	3	17387	78.35	0.87** (0.82, 0.91)
Breast screening	4	15894	72.54	0.64** (0.61, 0.68)
Round 1: 1989–92	5	5224	68.09	0.53** (0.49, 0.56)
	6 & 7 (Most)	3193	61.13	0.41** (0.38, 0.45)
	1 & 2 (Least)	17374	80.99	1 (-)
	3	18390	79.28	0.91** (0.86, 0.95)
Breast screening	4	15847	75.12	0.73** (0.69, 0.77)
Round 2: 1992–95	5	5051	68.62	0.53** (0.50, 0.57)
	6 & 7 (Most)	3020	61.39	0.42** (0.38, 0.45)
	1 (Least)	16903	82.18	1 (-)
	2	17002	81.27	0.95+ (0.90, 1.00)
Breast screening	3	17228	80.50	0.91** (0.86, 0.96)
Round 5: 2001–04	4	17117	76.37	0.72** (0.68, 0.76)
	5 (Most)	17351	67.60	0.48** (0.45, 0.50)
	1 (Least)	16107	67.78	1 (-)
	2	23420	66.95	0.96* (0.92, 1.00)
Bowel screening	3	25225	65.03	0.88** (0.84, 0.91)
Round 1: 2000–02	4	28301	58.68	0.68** (0.66, 0.71)
	5 (Most)	29855	46.34	0.44** (0.42, 0.45)
	1 (Least)	14444	63.18	1 (-)
	2	21831	61.45	0.92** (0.88, 0.96)
Bowel screening	3	24090	59.55	0.84** (0.81, 0.88)
Round 2: 2003–05	4	26852	52.80	0.66** (0.63, 0.68)
	5 (Most)	28823	40.98	0.43** (0.41, 0.45)

+ Non-significant p > 0.05

* Significant at p < 0.05

** Significant at p < 0.001